NuVasive received regulatory Shonin approval for products supportive of the eXtreme Lateral Interbody Fusion surgical procedure in April 2013 and trained many surgeons in the procedure. The company also reported case volume growth with the Precept, Armada and Co-Roent systems and implants.
More Articles on Spine Devices:
20 Spine Devices Receive FDA 510(k) Clearance in March
LDR Announces Follow-On Public Offering
VertiFlex Submits Final PMA Module for FDA for Superion Interspinous Spacer
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
